2021 European Pharmaceutical Investigator Initiated Study Virtual Conference
Event summary
The 2021 European Pharma Investigator Initiated Study Virtual Conference is designed to bring together the industry’s best minds under one roof to address current challenges and highlight novel solutions. Attendees will hear the best strategies on IIS selection, project management, study contracting, supply chain management and fulfilling the regulatory body’s expectations wherever applicable.
At this Virtual Conference, you will be able to network with your peers including leading pharma innovators and service providers. The wealth of knowledge and advice at the conference can help you with your biggest concerns such as reviewing proposals, monitoring multi-centered IISs, ensuring ROI, developing protocols for commercial & scientific interest and negotiating contracts for IPs, finance and data privacy. These highly interactive sessions will be reinforced with real-life business examples, case studies, Q&A sessions, panel debates and interactive workshops to drive home the lessons to be learned.
For more information, please email Rebecca Lanz.
Featured agenda item
Impact of GDPR and Clinical Trials Regulation (CTR) on IIS
November 17, 9:15 am ET
Cooley partner Elisabethann Wright will speak on this panel.
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.